Capital International Sarl’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.7M	Sell	53,349 -66,003	-55%	-$22.5M	0.29%	85
2025 Q4	$47.5M	Sell	119,352 -10,350	-8%	-$4.58M	0.76%	36
2025 Q3	$59.1M	Buy	129,702 +1,416	+1%	+$577K	1.02%	22
2025 Q2	$41.8M	Buy	128,286 +7,126	+6%	+$1.97M	0.8%	30
2025 Q1	$32.7M	Buy	121,160 +6,018	+5%	+$1.55M	0.74%	38
2024 Q4	$27.1M	Sell	115,142 -19,931	-15%	-$5.24M	0.63%	44
2024 Q3	$37.1M	Buy	135,073 +25,258	+23%	+$6.58M	0.95%	30
2024 Q2	$26.7M	Buy	109,815 +36,706	+50%	+$5.79M	0.81%	33
2024 Q1	$10.9M	Sell	73,109 -14,248	-16%	-$2.38M	0.36%	77
2023 Q4	$16.7M	Buy	87,357 +435	+0.5%	+$74.1K	0.63%	54
2023 Q3	$15.4M	Buy	86,922 +2,523	+3%	+$481K	0.7%	46
2023 Q2	$16M	Buy	84,399 +7,309	+9%	+$1.45M	0.72%	44
2023 Q1	$15.4M	Buy	77,090 +10,214	+15%	+$2.15M	0.78%	36
2022 Q4	$15.9M	Buy	66,876 +22,551	+51%	+$4.81M	1.12%	15
2022 Q3	$8.87M	Buy	44,325 +13,456	+44%	+$2.57M	0.72%	35
2022 Q2	$4.5M	Buy	30,869 +17,554	+132%	+$2.49M	0.36%	93
2022 Q1	$2.17M	Buy	+13,315	New	+$2.03M	0.11%	185